Professor, College of Pharmacy - Medicinal Chemistry and Pharmacognosy
Assistant Director, Center for Biomolecular Sciences
Affiliate, Center for Biomolecular Sciences
I have spent over 25 years studying, researching, and mentoring in the field of molecular microbiology and bacterial pathogenesis. In 2008, I established an independent research laboratory at the University of Illinois at Chicago, focusing on chemical signaling in Gram-positive bacterial pathogens. My laboratory has helped to identify a widespread protein family characterized as cytoplasmic pheromone receptors. It is our mission to identify signaling pathways in Gram-positive pathogens (including Streptococcus pyogenes, S. pneumoniae, S. agalactiae, and S. mutans), characterize their benefits in bacterial survival or pathogenesis, and elucidate mechanisms of signaling interference as potential anti-virulence strategies. My training began at the University of Wisconsin, where I earned a bachelor’s degree in genetics. I spent three years working as a laboratory specialist in the labs of Dr. Frederick Blattner (Wisconsin, 2004-2005) and Dr. June R. Scott (Emory, 2005-2007). I completed my PhD in 2002 in the Microbiology and Molecular Genetics graduate program at Emory University under the mentorship of Dr. June Scott; my thesis was based on the characterization of the CovRS twocomponent signal transduction system in the human pathogen Streptococcus pyogenes. My postdoctoral training at Princeton University was under the mentorship of Dr. Bonnie Bassler. I helped to elucidate the molecular mechanism of autoinducer-2 sensory transduction through the LuxPQ receptor of Vibrio harveyi. Now, as a professor in the departments of Medicinal Chemistry and Pharmacognosy, and Microbiology and Immunology, I am the principle investigator of several research grants and lead a lab comprised of six graduate students and two postdoctoral scientists. I enjoy teaching to both graduate and professional students at UIC.
Doctor of Pharmacy Program (Pharm D):
•Biomedical Chemistry (PHAR 423), 5 lectures + recitation, teaching concepts of signal transduction; microbial impact on human metabolism.
•Principles of Drug Action and Therapeutics 4: Immunology Respiratory (PHAR 504) 2 lectures, Disease-Modifying Anti-rheumatoid Drugs (DMARDs) and Biologic drugs; Immunity to Pathogens.
•Pharmaceutical Applications of Genomics and Bioinformatics (PMMP412), 1 lecture, discussing microbial genomes.
Doctor of Philosophy Program (Graduate Studies):
• (MIM 554, coordinator, 3cr) 4 contact hours, Molecular Aspects of Host Responses in Microbiology.
• Molecular Biology (GEMS 502, 6cr), 6 lecture hours, mechanisms of bacterial transcription, transcriptional regulation, and signal transduction.
• Advanced Pharmacognosy (PMPG 510, 511), 4 lectures, Antibiotic compounds; Quorum Sensing Inhibitors
• Special Topics in Microbiology-Grant Writing (MIM 594), 4 contact hours.
• (MIM 560) Current topics in microbial pathogenesis, 2 lectures.
Teaching and Supervision
PSCI Ph.D. Thesis Research (PSCI 599), 6/14/2021 – 8/6/2021
PhD Thesis Research (MIM 599), 5/17/2021 – 8/6/2021
PSCI Ph.D. Thesis Research (PSCI 599), 1/11/2021 – 4/30/2021
PhD Thesis Research (MIM 599), 1/11/2021 – 4/30/2021
Principles of Drug Action and Therapeutics VIII (408), 10/19/2020 – Present
PhD Thesis Research (MIM 599), 8/24/2020 – 12/4/2020
PSCI Ph.D. Thesis Research (PSCI 599), 8/24/2020 – 12/4/2020
Pharmacog Research Techniques (PSCI 520), 8/24/2020 – 12/4/2020
Molecular Aspcts of Microbiol (MIM 554), 8/24/2020 – 12/4/2020
Chemical profiling of bacterial-fungal interactions to elucidate mechanisms of growth and survival in multi-domain microbial communities, National Institutes of Health (National Center for Complementary and Integrative Health)., 1/1/2020 - 12/31/2020, Obligated Amount: $46016; Anticipated Amount: $46016
Incoming MTA - Cell-cell Signaling in Gram-positive Bacteria, Univ of Manitoba., 11/6/2019 - 11/5/2020, No Obligated Amount Set; No Anticipated Amount Set
Transcriptomic and Genomic Differences of Group A Streptococcus in Humans: Acute Infection Versus Carriage, State University of New York - Binghampton., 7/10/2019 - 6/30/2022, Obligated Amount: $45843; Anticipated Amount: $45843
Novel Biofilm Inhibitors of Oral Streptococci, National Institutes of Health (National Institute of Dental and Craniofacial Research)., 7/1/2019 - 6/30/2024, Obligated Amount: $414762; Anticipated Amount: $685330
Applying Ribo-Seq and RNA-Seq to identify quorum sensing pheromones and their regulons, National Institutes of Health (National Institute of Allergy and Infectious Diseases)., 2/19/2019 - 1/31/2022, Obligated Amount: $434568; Anticipated Amount: $434568
Outgoing MTA - Transfer of Bacterial Strains to Laura Cook, State University of New York - Binghampton., 10/31/2018 - 10/30/2019, No Obligated Amount Set; No Anticipated Amount Set
Outgoing MTA - Transfer of ATCC Bacterial Strain to Laura Cook, State University of New York - Binghampton., 10/29/2018 - 10/28/2019, No Obligated Amount Set; No Anticipated Amount Set
UIC Portal for Biomedical Research Careers (UIC PBRC) PREP, National Institutes of Health (National Institute of General Medical Sciences)., 1/1/2018 - 12/31/2022, Obligated Amount: $1149080; Anticipated Amount: $1512419
BWF Ad Hoc Grant ID# 1018487, Burroughs Wellcome Fund., 11/1/2017 - 10/31/2018, Obligated Amount: $1000; Anticipated Amount: $1000
Rahbari, KM, Chang, JC, Federle, MJ. (2021). A streptococcus quorum sensing system enables suppression of innate immunity. mBio, 12, (3). doi:10.1128/mBio.03400-20.
Gogos, Artemis, Federle, Michael J. (2021). #99: Streptococcus pyogenes Utilizes the Peptide-Based Rgg 2/3 Quorum Sensing System During Oropharyngeal Colonization. Journal of the Pediatric Infectious Diseases Society, 10, (Supplement_1), s10-s10. doi:10.1093/jpids/piaa170.031.
Rued, BE, Covington, BC, Bushin, LB, Szewczyk, G, Laczkovich, I, Seyedsayamdost, MR, Federle, MJ. (2021). Quorum sensing in streptococcus mutans regulates production of tryglysin, a novel ras-ripp antimicrobial compound. mBio, 12, (2), 1-25. doi:10.1128/mBio.02688-20.
Gogos, A, Federle, MJ. (2020). Colonization of the murine oropharynx by streptococcus pyogenes is governed by the Rgg2/3 quorum sensing system. Infection and Immunity, 88, (10). doi:10.1128/IAI.00464-20.
Capodagli, GC, Tylor, KM, Kaelber, JT, Petrou, VI, Federle, MJ, Neiditch, MB. (2020). Structure-function studies of Rgg binding to pheromones and target promoters reveal a model of transcription factor interplay. Proceedings of the National Academy of Sciences of the United States of America, 117, (39), 24494-24502. doi:10.1073/pnas.2008427117.
Bushin, LB, Covington, BC, Rued, BE, Federle, MJ, Seyedsayamdost, MR. (2020). Discovery and Biosynthesis of Streptosactin, a Sactipeptide with an Alternative Topology Encoded by Commensal Bacteria in the Human Microbiome. Journal of the American Chemical Society, 142, (38), 16265-16275. doi:10.1021/jacs.0c05546.
Cook, LCC, Chatterjee, N, Li, Y, Andrade, J, Federle, MJ, Eichenbaum, Z. (2019). Transcriptomic analysis of streptococcus pyogenes colonizing the vaginal mucosa identifies hupy, an MtsR-regulated adhesin involved in heme utilization. mBio, 10, (3). doi:10.1128/mBio.00848-19.
Pavlova, SI, Wilkening, RV, Federle, MJ, Lu, Y, Schwartz, J, Tao, L. (2019). Streptococcus endopeptidases promote HPV infection in vitro. MicrobiologyOpen, 8, (1). doi:10.1002/mbo3.628.
Gogos, A, Federle, MJ. (2019). Modeling streptococcus pyogenespharyngeal colonization in the mouse. Frontiers in Cellular and Infection Microbiology, 9, (MAY). doi:10.3389/fcimb.2019.00137.
2020, ASM American Academy of Microbiology Fellow, American Society of Microbiology
Ph.D., Emory University, United States, 2002
B.S., University of Wisconsin–Madison, United States, 1994
Postdoctoral Research Fellow and Research Associate, Howard Hughes Medical Institute, United States, 2008
Federle, Michael. (2021 June 24). Identifying and Exploiting Bacterial Communication Networks to Manipulate Bacterial Pathogens. Virtual Streptococcal Biology Seminar Series.